First National Corp’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-452
Closed -$37K – 160
2019
Q1
$37K Hold
452
– – 0.02% 241
2018
Q4
$34K Buy
+452
New +$35.3K 0.02% 246

Other funds holding AZN

First National Corp's AZN Position: Q2 2019 in Review

First National Corp sold out of AstraZeneca (AZN) in Q2 2019, closing a stake of 452 shares — an estimated $37K sold.

First National Corp first reported a position in AZN in Q4 2018 and held it in 2 quarters. The position peaked at $37K in Q1 2019. 546 funds tracked by Wall St. Rank hold AZN as of Q2 2019.

  • First National Corp reported no remaining AstraZeneca position as of Q2 2019 after selling out during the quarter.
  • First National Corp sold 452 AstraZeneca shares in Q2 2019, an estimated $37K.
  • First National Corp first reported a position in AstraZeneca in Q4 2018 and held it in 2 quarters.
  • First National Corp's AstraZeneca position peaked at $37K in Q1 2019.
  • 546 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2019.

Based on First National Corp's 13F filing for Q2 2019, filed 30 Jul 2019.